Cardio Diagnostics Holdings, Inc.
CDIO
Rank in Stocks
#30363
Cardio Diagnostics Holdings, Inc. specializes in creating and bringing to... Cardio Diagnostics Holdings, Inc. specializes in creating and bringing to market advanced clinical diagnostic tools that leverage epigenetic insights to address cardiovascular disease. Among their key offerings is Epi+Gen CHD, a test designed to assess an individual's three-year risk for developing symptomatic coronary heart disease. This company, headquartered in Chicago, Illinois, was established in 2017.
Share Price
$1.82
Last synced: 2026-11-09
Market Cap
$5.39M
Change (1 day)
10.24%
Change (1 year)
-52.23%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Cardio Diagnostics Holdings, Inc. (CDIO)
Category
Healthcare
Operating Margin for Cardio Diagnostics Holdings, Inc. (CDIO)
Operating Margin as of November 2026 TTM: -44,690.68%
According to Cardio Diagnostics Holdings, Inc.'s latest financial reports, its current operating margin (TTM) is -44,690.68%. At the end of 2025 the company had an operating margin of -43,737.46%.
Operating Margin history for Cardio Diagnostics Holdings, Inc. from 2020 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -44,690.68% | 2.18% |
| 2025 | -43,737.46% | 82.41% |
| 2024 | -23,977.86% | -43.50% |
| 2023 | -42,440.43% | -91.14% |
| 2022 | -478,784.32% | 595.28% |
| 2021 | -68,862.15% | 0.00% |
| 2020 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.00% |
US
|
|
| -149.01% | -100.00% |
US
|
|
| 25.57% | -100.00% |
AU
|
|
| 31.23% | -100.00% |
BE
|
|
| 29.35% | -100.00% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Cardio Diagnostics Holdings, Inc.'s operating margin
What is Cardio Diagnostics Holdings, Inc.'s operating margin?
Cardio Diagnostics Holdings, Inc.'s operating margin is -44,690.68%, as of Nov 2026.
What was Cardio Diagnostics Holdings, Inc.'s operating margin in 2025?
In 2025, Cardio Diagnostics Holdings, Inc.'s operating margin was -43,737.46%, compared with -23,977.86% in 2024.
How has Cardio Diagnostics Holdings, Inc.'s operating margin changed since 2020?
From 2020 to 2025, Cardio Diagnostics Holdings, Inc.'s operating margin was highest in 2020 (0.00%) and lowest in 2022 (-478,784.32%).
How does Cardio Diagnostics Holdings, Inc.'s operating margin compare with similar companies?
Cardio Diagnostics Holdings, Inc.'s operating margin (-44,690.68%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.